A comparison of 68Ga-PSMA PET/MR, 18F-FDG PET/CT and biochemical monitoring in neuroendocrine prostate cancer: a case report
Neuroendocrine prostate cancer (NEPC) is a rare, aggressive subtype with hormonal resistance and poor prognosis. Traditional serum biomarkers such as prostate-specific antigen (PSA) and neuron-specific enolase (NSE) are often present at low or normal levels, making it difficult to accurately reflect disease burden an...